Thomas Frost Patterson MD
Professor of Medicine, University Tex San Antonio
Join to View Full Profile
8300 Floyd Curl Drive3rd Floor -3ASan Antonio, TX 78229
Phone+1 210-450-9800
Fax+1 210-450-6018
Dr. Patterson is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Thomas Patterson, MD is an infectious disease specialist based in San Antonio, TX. He completed his education and training at esteemed institutions such as Yale-New Haven Medical Center, Vanderbilt University Medical Center, and McGovern Medical School at UTHealth. His expertise lies in emerging infectious diseases, with a specific interest in mycology. He is an accomplished researcher and contributor to the field, with several publications in reputable medical journals revolving around fungal diseases, the process of repurposing drug libraries, and the research on COVID recovery.
Education & Training
Yale-New Haven Medical CenterFellowship, Infectious Disease, 1986 - 1989- Yale-New Haven Medical CenterResidency, Internal Medicine, 1985 - 1986
Vanderbilt University Medical CenterResidency, Internal Medicine, 1983 - 1985
McGovern Medical School at UTHealthClass of 1983
Certifications & Licensure
TX State Medical License 1983 - 2027
TN State Medical License 1985 - 1995
CT State Medical License 1985 - 1993
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Infectious Disease
Publications & Presentations
PubMed
- The next-generation polyene EL219 is efficacious in an experimental model of central nervous system coccidioidomycosis caused by.Nathan P Wiederhold, Laura K Najvar, Rosie Jaramillo, Marcos Olivo, Thomas F Patterson
Antimicrobial Agents and Chemotherapy. 2026-03-04 - 1 citationsEvaluation of Interventions for Cognitive Symptoms in Long COVID: A Randomized Clinical Trial.David S Knopman, Deborah Koltai, Daniel T Laskowitz, Jacqueline Becker, Leigh Charvet
JAMA Neurology. 2026-01-01 - 2 citationsLong COVID trajectories in the prospectively followed RECOVER-Adult US cohort.Tanayott Thaweethai, Sarah E Donohue, Jeffrey N Martin, Mady Hornig, Jarrod M Mosier
Nature Communications. 2025-11-17
Journal Articles
- Remdesivir for the Treatment of Covid-19 — Final ReportAneesh K Mehta, Barry S Zingman, Andre C Kalil, Helen Y Chu, Robert W Finberg, Kerry Dierberg, Victor Tapson, Lanny Hsieh, Thomas F Patterson, Daniel A Sweeney, Willia..., The New England Journal of Medicine
Press Mentions
Analysis Reveals 31% Elevated Danger of Lengthy COVID in GirlsJanuary 23rd, 2025- Females Have a 31% Higher Associated Risk of Developing Long COVID, UT Health San Antonio-Led RECOVER Study ShowsJanuary 22nd, 2025
- Females Have a 31% Higher Associated Risk of Developing Long COVID, UT Health San Antonio-Led RECOVER Study ShowsJanuary 22nd, 2025
Grant Support
- Interactions of SARS-CoV-2 infection and genetic variation on the risk of cognitive decline and Alzheimer’s disease in Ancestral and Admixed PopulationsUNIVERSITY OF TEXAS HLTH SCIENCE CENTER2023–2028
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
